Purpose
The aim of this study is to explore potential complications and risk factors associated with revision TSA in patients with congestive heart failure (CHF).
Methods
This study examined all individuals who underwent revision total shoulder arthroplasty (TSA) from 2015 to 2022, sourced from the American College of Surgeons National Surgical Quality Improvement database. The analysis encompassed patient demographics, comorbidities, and 30-day postoperative complications. Logistic regression was employed to analyze the postoperative complications linked to patients with preoperative CHF.
Results
Compared to patients without CHF, patients with CHF were significantly associated with dependent functional status (P < .001), chronic obstructive pulmonary disease (P < .001), and hypertension (P = .002). Compared to patients without CHF, patients with CHF were independently associated with a significantly greater likelihood of experiencing any complication (OR 2.19, 95% CI 1.12–4.29; P = .022) and non-home discharge (OR 3.02, 95% CI 1.37–6.65; P = .006).
Conclusion
Congestive heart failure was identified as an independent risk factor for experiencing any complication and non-home discharge in patients undergoing revision TSA. Awareness of the cardiovascular health status of a patient and its severity can influence the decision-making process when considering revision TSA.
Level of evidence III
Retrospective Cohort Comparison Using Large Database; Prognosis Study.
